Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Unjha Formulations OCF Yield % Related Terms
Unjha Formulations OCF Yield % Historical Data
* Premium members only.
The historical data trend for Unjha Formulations's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unjha Formulations OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Unjha Formulations's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unjha Formulations (BOM:531762) has a OCF Yield % of 11.34 as of Jul. 23, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Unjha Formulations and its competitors. Over the past decade, Unjha Formulations' OCF Yield % has ranged from 11.34 to 11.34. According to the industry distribution chart, Unjha Formulations ranks #178 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 17.7%.
Is Unjha Formulations' OCF Yield % too high?
Unjha Formulations' current OCF Yield % is 11.34. Over the past 10 years, this metric has ranged from a low of 11.34 to a high of 11.34. The Drug Manufacturers industry median OCF Yield % is 3.62. Unjha Formulations' value of 11.34 is 213.3% above this industry median. Based on the distribution chart, Unjha Formulations ranks #178 out of 1006 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Unjha Formulations has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Unjha Formulations' OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Unjha Formulations ranks #178 out of 1006 companies for OCF Yield %. This places Unjha Formulations in the top 18% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.62. Unjha Formulations' value of 11.34 is 213.3% above this benchmark. Historically, Unjha Formulations' own OCF Yield % has ranged from 11.34 to 11.34 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.62, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unjha Formulations's current OCF Yield % of 11.34 is 213.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Unjha Formulations and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unjha Formulations's current OCF Yield % is 11.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unjha Formulations stock overvalued right now?
Based on GuruFocus' analysis, Unjha Formulations (BOM:531762) is currently considered Fairly Valued. The stock's GF Value™ is ₹23.14, compared to a current price of ₹23.89 — trading 3.2% above its estimated fair value. The current OCF Yield % is 11.34 and 213.3% above the Drug Manufacturers industry median of 3.62. Unjha Formulations' overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Unjha Formulations (BOM:531762), the current OCF Yield % is 11.34 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unjha Formulations (BOM:531762) Overvalued in 2026?
Based on GuruFocus' analysis, Unjha Formulations stock appears to be overvalued.
The current stock price of ₹23.89 is trading 3.2% above its estimated GF Value™ of ₹23.14.
GuruFocus considers Unjha Formulations to be Fairly Valued.
Key valuation signals for BOM:531762:
OCF Yield %: 11.34
GF Value™: ₹23.14 vs. price of ₹23.89 (3.2% above fair value)
Industry Position: 213.3% above the Drug Manufacturers median (#178 of 1006)
No single metric tells the full story. See the BOM:531762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.
72GF Score
Get the complete analysis for BOM:531762
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531762 has been successfully added to your 
